Related Experiment Video
Updated: Jun 15, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Onset of modified measles after etanercept treatment in rheumatoid arthritis]
Eigo Takahashi1, Daitaro Kurosaka, Ken Yoshida
1Division of Rheumatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Abstract:
Treatment with corticosteroid and etanercept was started for a 69-year-old woman with rheumatoid arthritis. Eight weeks later, she developed fever and anorexia, and was admitted to our hospital with a poor general condition. With the suspicion of bacterial infection, antibiotic treatment was started on the first hospital day, but was ineffective. From the fourth hospital day, multiple generalized, partially confluent, erythematous papules appeared. To exclude viral infection, we measured antibody titers against various viruses, and found that the levels of anti-measles IgG and IgM antibodies were elevated, which led to a diagnosis of modified measles. During the course of measles, she developed severe leukopenia, and bone marrow aspiration revealed bone marrow suppression. This was considered to be due to measles infection, leading to a diagnosis of severe modified measles. This is the first case report of modified measles which developed during the use of an anti-TNF-alpha preparation, and suggests that immunosuppression induced by the preparation may play a role in measles reinfection and its aggravation.
Insights
A 69-year-old woman on etanercept for rheumatoid arthritis developed severe modified measles and bone marrow suppression. This case suggests anti-TNF-alpha therapy may increase measles risk and severity.
Area of Science:
- Immunology
- Infectious Diseases
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- Biologic therapies, such as anti-TNF-alpha agents (e.g., etanercept), are used to manage RA.
- Immunosuppression from these therapies can increase susceptibility to infections.
Observation:
- A 69-year-old woman with RA developed fever, anorexia, and rash after starting etanercept and corticosteroids.
- Initial bacterial infection was suspected, but antibiotic treatment was ineffective.
- Elevated measles IgG and IgM antibody titers confirmed a diagnosis of modified measles.
Findings:
- The patient experienced severe leukopenia and bone marrow suppression, attributed to the measles infection.
- This represents the first reported case of modified measles occurring during anti-TNF-alpha therapy.
- The measles infection was severe and complicated by bone marrow suppression.
Implications:
- Anti-TNF-alpha therapy may predispose patients to measles reinfection or atypical presentations.
- Immunosuppression induced by etanercept could exacerbate measles severity.
- Clinicians should consider measles in immunocompromised patients presenting with febrile exanthems.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rocky Mountain Spotted Fever
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Myocarditis III: Medical Management
Respiratory Syncytial Virus Disease